Back to Search
WALLACE AKERLEY, MD
MD
Medical Oncology Physician
NPI: 1346330966Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
5173577-1205(UT)
Research & Publications (20)
A phase II study of erlotinib as initial treatment for patients with stage IIIB-IV non-small cell lung cancer.
PMID 19179899·J Thorac Oncol·2009
3-trial
Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.
PMID 17545848·J Thorac Oncol·2007
3-trial
Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer.
PMID 16878327·Cancer·2006
3-trial
Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.
PMID 12733147·Cancer·2003
3-trial
A phase I study of a weekly schedule of paclitaxel and carboplatin in patients with advanced carcinoma.
PMID 12404295·Cancer·2002
3-trial
The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors.
PMID 19660684·Semin Oncol·2009
6-review
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer.
PMID 19652624·J Thorac Oncol·2009
4-observational
NCCN Task Force Report: mTOR inhibition in solid tumors.
PMID 18926092·J Natl Compr Canc Netw·2008
6-review
Oncologists' current opinion on the treatment of colon carcinoma.
PMID 17896910·Anticancer Agents Med Chem·2007
6-review
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.
PMID 17404369·J Clin Oncol·2007
2-rct
Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer.
PMID 17075122·J Clin Oncol·2006
3-trial
Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.
PMID 16098244·Clin Lung Cancer·2005
3-trial
Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer.
PMID 16043262·Lung Cancer·2005
8-other
Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer.
PMID 15913910·Int J Radiat Oncol Biol Phys·2005
8-other
Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity.
PMID 15205196·Ann Oncol·2004
1-meta
Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure.
PMID 12222966·Cell Mol Life Sci·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1950 CIRCLE OF HOPE, CLINIC 2B
SALT LAKE CITY, UT 84112 - Phone
- (801) 585-0100
Quick Facts
- NPI
- 1346330966
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile